Gulf & Middle East · Regional markets · Globes

Teva again raises guidance as branded drugs lift revenue

Published by Globes · Israel 2 h ago

Revenue in the third quarter was $4.4 billion, while analysts had predicted $4.2 billion and non-GAAP earnings per share was $0.86, well above the analysts’ consensus of $0.72.

Read the full article on Globes Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (en.globes.co.il)

Also worth reading

AGBI

Qatar-backed venture to fund UK’s $27bn data centre project

The Peninsula

Prime Minister receives Minister-President of the German State of Bavaria

Arabian Business

Gold accounts for over 50% of UAE trading on Capital.com as stop-loss orders rise

Zawya

Mideast Stocks: Gulf bourses mixed as fears over US strikes offset Iran-Saudi talks

Arab News Business

Midterm elections are coming to a close as voters pass judgment on Trump’s second term

Khaleej Times Business